Cases 1 - 2 of 2
In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
as 2:2014md02510
Counter Defendant:
Invitae Corporation, Myriad Genetics, Quest Diagnostics and others
Counter Claimant:
Pathway Genomics and Ambry Genetics
Undetermined:
Labroratory Corporation of America Holdings, AARP, GeneDX and others
In Re:
BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
Cause Of Action: 35 U.S.C. § 0271
University of Utah Research Foundation et al v. Ambry Genetics
as 2:2013cv00640
Plaintiff:
University of Utah Research Foundation , Trustees of the University of Pennsylvania , HSC Research and Development Limited Partnership and others
Defendant:
Ambry Genetics
Counter_claimant:
Ambry Genetics
Counter_defendant:
Endorecherche , HSC Research and Development Limited Partnership , Myriad Genetics and others
Cause Of Action: 35 U.S.C. § 0271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
